This stock has m-a-n-i-p-u-l-a-t-i-o-n written all over it! Also, there must be something wrong with this one due to the lack of institutional ownership. No stock goes down as much and as fast as this one did when it got its May26 FDA approval without any logical explanation, especially since it is so heavily retail-owned. So, the obvious conclusion is that the locating and borrowing of shares happened pre-approval date by institutions. They knew that whether or not the drug got approveal, they could knock it down-- and they did. SOOOOO - conclusion--- they must not think much of the science or the mgmt teams ability to execute a business plan or both!